Raj Kumar

Raj Kumar is an accomplished Associate Director Study Leader in Early Oncology Clinical at AstraZeneca, bringing over 16 years of experience in global Phase II and III oncology trials. Previously, they held various leadership roles at Boehringer Ingelheim, Roche, and GlaxoSmithKline, consistently earning recognition for excellence in project management and clinical research. Raj has a strong academic background, with a Master’s in Clinical Research from Cranfield University and an MD in Homeopathic Pediatrics from Rajasthan Vidyapeeth. Currently, they lead initiatives to enhance trial outcomes while supporting a team of project managers and CRAs at AstraZeneca.